Literature DB >> 34339170

Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment.

Shan Gao1, Xiaoye Yang1, Jiangkang Xu1, Na Qiu1, Guangxi Zhai1.   

Abstract

Immunotherapy that harnesses the human immune system to fight cancer has received widespread attention and become a mainstream strategy for cancer treatment. Cancer immunotherapy not only eliminates primary tumors but also treats metastasis and recurrence, representing a major advantage over traditional cancer treatments. Recently with the development of nanotechnology, there exists much work applying nanomaterials to cancer immunotherapy on the basis of their excellent physiochemical properties, such as efficient tissue-specific delivery function, huge specific surface area, and controllable surface chemistry. Consequently, nanotechnology holds significant potential in improving the efficacy of cancer immunotherapy. Nanotechnology-based immunotherapy mainly manifests its inhibitory effect on tumors via two different approaches: one is to produce an effective anti-tumor immune response during tumorigenesis, and the other is to enhance tumor immune defense ability by modulating the immune suppression mechanism in the tumor microenvironment. With the success of tumor immunotherapy, understanding the interaction between the immune system and smart nanomedicine has provided vigorous vitality for the development of cancer treatment. This review highlights the application, progress, and prospect of nanomedicine in the process of tumor immunoediting and also discusses several engineering methods to improve the efficiency of tumor treatment.

Entities:  

Keywords:  immune defense; immune suppression; immunotherapy; nanotechnology; smart nanomedicine; tumor immunoediting; tumor microenvironment; tumor treatment

Year:  2021        PMID: 34339170     DOI: 10.1021/acsnano.1c02103

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  7 in total

Review 1.  Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells.

Authors:  Chenmala Karthika; Raman Sureshkumar; Mehrukh Zehravi; Rokeya Akter; Faraat Ali; Sarker Ramproshad; Banani Mondal; Milton Kumar Kundu; Abhijit Dey; Md Habibur Rahman; Angela Antonescu; Simona Cavalu
Journal:  Life (Basel)       Date:  2022-05-30

2.  Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.

Authors:  Jiali Luo; Xue Wang; Zhan Shi; Yiqing Zeng; Liangcan He; Jing Cao; Yu Sun; Tao Zhang; Pintong Huang
Journal:  J Nanobiotechnology       Date:  2022-05-14       Impact factor: 9.429

3.  A novel biomimetic nanomedicine system with anti-inflammatory and anti-osteoporosis effects improves the therapy efficacy of steroid-resistant nephrotic syndrome.

Authors:  Jian Li; Mingyi Zhao; Xinying Xiang; Qingnan He; Rong Gui
Journal:  J Nanobiotechnology       Date:  2021-12-13       Impact factor: 10.435

Review 4.  Applications of nanomaterials for gastrointestinal tumors: A review.

Authors:  Rahul Kanaoujiya; Dipiti Porwal; Shekhar Srivastava
Journal:  Front Med Technol       Date:  2022-09-01

5.  Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model.

Authors:  Qiongli Su; Qiuhong Tan; Xin Liu; Ling Wu
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

6.  Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy.

Authors:  Jiulong Zhang; Xiaoyan Sun; Xiufeng Zhao; Chunrong Yang; Menghao Shi; Benzhuo Zhang; Haiyang Hu; Mingxi Qiao; Dawei Chen; Xiuli Zhao
Journal:  Acta Pharm Sin B       Date:  2022-05-16       Impact factor: 14.903

7.  Adaptive Recombinant Nanoworms from Genetically Encodable Star Amphiphiles.

Authors:  Md Shahadat Hossain; Jingjing Ji; Christopher J Lynch; Miguel Guzman; Shikha Nangia; Davoud Mozhdehi
Journal:  Biomacromolecules       Date:  2021-12-23       Impact factor: 6.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.